Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Date

08 September 2026

Generic Drugmakers See Opening to Close Africa’s Medicine Access Gaps

In an article for Health Business, Samwel Doe Ouma covers the release of the Access to Medicine Foundation’s new report from its Generic & Biosimilar Medicines Programme, ‘Africa’s evolving healthcare landscape: How generic medicine manufacturers are expanding medicine supply and availability.’

Direct links

Read the full article

Africa’s healthcare landscape is becoming more complex as demand for medicines for communicable and non-communicable diseases rise across the continent.

“Manufacturers across the ecosystem will play an important role in determining whether medicine supply evolves alongside” changing healthcare needs, the article quotes Claudia Martínez, Director of Research at the Access to Medicine Foundation.

The article points out the opportunities that the current market conditions create for the industry but also notes limits of what companies can achieve on their own, as detailed in the report. Unpredictable demand, fragmented markets and complex manufacturing requirements all create challenges for manufacturers to respond to the need to address gaps in access to medicine.

The article also notes that true progress will require action not only from drugmakers but also from governments, regulators, procurement agencies, development finance institutions and global health organisations.

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

In the media

Read the latest media coverage of our work
Media

As NCDs rise in Africa, generic drugmakers see a growing market

08 September 2026
Media

Africa’s Pharmaceutical Manufacturing Push Faces a Race Against Rising Medicine Needs

08 September 2026
Media

Report highlights opportunity for generic drug makers in Africa

08 September 2026

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved